Evolus (stock symbol: EOLS) Logo in transparent PNG format

About Evolus

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

• Website domain: evolus.com
• Employees: 174
• Marketcap: $0.47 Billion USD